3 ASX shares to own if Australia tips into a recession

CSL Limited (ASX: CSL) looks a good bet for overseas exposure.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Generally macro-economic conditions or your perception of them should not affect what shares you decide to buy for your portfolio. This is because as an investor you should always aim to buy high-quality businesses on attractive valuations.

For example if you buy poor or non-investment grade businesses you're likely to get poor returns irrespective of whether we're in an economic boom or recession.

Vice versa applies in that if you buy a strong business on a reasonable valuations you should achieve good total returns over say a 3 to 5 year period and be able to ride out the negative consequences of any recession.

However, as the topic of what shares to own in the event of a recession seems to be popular with readers, I'd suggest if you were worried about a recession in Australia there are a couple of qualities in companies to look for.

First you should own companies with a large majority of overseas earnings and second you should own companies that benefit from a weaker Australian dollar.

This is not rocket science as companies that do little business in Australia are least likely to be affected by a recession, while a lower Australian dollar and rate cuts are logical symptoms of a recession.

In all honesty it would also make sense to probably sell a lot of your shares if you were convinced Australia or the world were set to fall into recession, but if you did want to own some shares as a bulwark against it the following three tick the boxes.

CSL Limited (ASX: CSL) earns around 98% of its profits and revenues overseas and investors also benefit as the Australian dollar falls as dividends for example are declared in U.S. dollars before being paid in Australian dollars.

Fisher & Paykel Healthcare Limited (ASX: FPH) is a New Zealand based retailer of equipment used to treat sleep disorders in patients. It has a superb track record of growth thanks to its large addressable markets and earns almost all its profits outside Australia.

BETASHARES ETF (ASX: NDQ) is an exchange traded fund that tracks the performance of the NASDAQ-100 Index of the US's leading tech companies. As such it provides excellent diversification away from the mining and residential housing leveraged Australian economy, while giving exposure to the world's best tech companies. You can't ask for much more than that!

Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of BETANASDAQ ETF UNITS. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »